Mar 21 |
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript
|
Mar 21 |
RANI: 2023 Results
|
Mar 21 |
Q4 2023 Rani Therapeutics Holdings Inc Earnings Call
|
Mar 20 |
Earnings Scheduled For March 20, 2024
|
Mar 15 |
Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
|
Mar 12 |
Individual investors own 40% of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shares but private companies control 47% of the company
|
Feb 20 |
RANI: INITIATION – Realizing Oral Administration of Biologics
|
Feb 5 |
Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)
|
Dec 8 |
Rani Therapeutics CEO discloses purchase of 10K shares
|
Dec 7 |
What Makes Rani Therapeutics Holdings, Inc. (RANI) a New Buy Stock
|